REBECCA HARRIS: Open Payments
NPI 1952774143 · MOREHEAD CITY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$644 in 35 payments from 14 companies in 2025. Trend: 2023 $1,232 · 2024 $1,384 · 2025 $644
Food & beverage: $644
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $110 |
| E.R. Squibb & Sons, L.L.C. | 5 | $92 |
| SCPHARMACEUTICALS INC. | 4 | $79 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $72 |
| Merck Sharp & Dohme LLC | 4 | $64 |
| Baxter Healthcare | 1 | $51 |
| Novo Nordisk Inc | 2 | $35 |
| Amgen Inc. | 2 | $28 |
| BridgeBio Pharma, Inc. | 1 | $22 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
Products named: LEQVIO, FUROSCIX, Kerendia, VERQUVO, CAMZYOS, Hillrom - Cardiac Ambulatory Monitor, ELIQUIS, REPATHA.
Industry payments across NC — which companies pay providers there.
